Splice-switching Antisense Oligonucleotides as a Therapeutic for Alzheimer's Disease

Text Registration

Splice-switching Antisense Oligonucleotides as a Therapeutic for Alzheimer's Disease

Status

Published

on 7 Dec 2020

Year of Creation

2018

Jennifer Lynn Chang

Registration Number

TX0008923773

on 7 Dec 2020

The U.S. Copyright record (Registration Number: TX0008923773) dated 7 Dec 2020, pertains to an electronic file (eService) titled "Splice-switching Antisense Oligonucleotides as a Therapeutic for Alzheimer's Disease" created in 2018. The copyright holder is Jennifer Lynn Chang, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Jennifer Lynn Chang.

Jennifer Lynn Chang

Application Details

Registration Number

TX0008923773

Registration Date

12/7/2020

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

ISBN

978-0-355-80756-1

Preexisting Material

previously published text

Personal Authors

Jennifer Lynn Chang

Notes

Local Copyright Note: Regarding limitation of claim: Statement added by Copyright Office from information found in deposit

Material Matter Claimed Note: text

Statements

Application Title Statement: Splice-switching Antisense Oligonucleotides as a Therapeutic for Alzheimer's Disease

Author Statement: Jennifer Lynn Chang Domicile: United States Citizenship: United States Authorship: text

Notes

Local Copyright Note: Regarding limitation of claim: Statement added by Copyright Office from information found in deposit

Material Matter Claimed Note: text

Statements

Application Title Statement: Splice-switching Antisense Oligonucleotides as a Therapeutic for Alzheimer's Disease

Author Statement: Jennifer Lynn Chang Domicile: United States Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.